AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)

CUSIP: 00847X104

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+363,742
Put/Call ratio
63%
SEC-reported price per share
$51.64
Number of holders
168
Value change
+$56,136,770
Number of buys
74
Open additional details 1 more signal available
Number of sells
103
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
59,431,072

Security key

00847X104

Report period

Q1 2021

Institutions

168

Top holders

10

Ownership snapshot

Top reported holders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 13%
VANGUARD GROUP INC 9.5%
BlackRock Finance, Inc. 7.5%
FMR LLC 7.3%
Bellevue Group AG 7.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
13%
$341,327,000
7,877,370 shares
31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
9.5%
$243,762,000
5,625,713 shares
31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
7.5%
$194,335,000
4,485,000 shares
31 Dec 2020
FMR LLC
13F
Company
13F
7.3%
$187,994,000
4,338,667 shares
31 Dec 2020
Bellevue Group AG
13F
Company
13F
7.1%
$182,029,000
4,201,002 shares
31 Dec 2020
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
5%
$128,791,000
2,972,322 shares
31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
168
Shares
65,233,267
Rows available
168
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
189
Q1 2021 holders
168
Holder diff
-21
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .